CAR-T viral vector CDMO

by cailynn on Jun 17th, 2025 09:41 AM

CAR-T viral vector CDMO

services ensure high-quality vector production for gene therapy applications. These services optimize lentiviral and retroviral vector manufacturing, supporting CAR-T cell engineering and therapeutic development. By enhancing scalability and regulatory compliance, viral vector CDMO solutions play a crucial role in advancing cell-based immunotherapies.